Using C. elegans to screen for targets of ethanol and behavior-altering drugs

Andrew G. Davies1, Steven L. McIntire

  • 1Ernest Gallo Clinic and Research Center, Department of Neurology, Programs in Neuroscience and Biomedical Science, University of California, San Francisco. 5858 Horton Street, Suite 200, Emeryville, California 94608. USA.

Insights

This study details a genetic screen in Caenorhabditis elegans to identify genes affecting alcohol

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Caenorhabditis elegans is a valuable model for studying neuroactive compounds.
  • Identifying specific targets of ethanol's behavioral effects in vertebrates remains challenging.
  • Genetic screens offer an unbiased method to find genes involved in drug responses.

Purpose of the Study:

  • To present a detailed methodology for a genetic screen in C. elegans.
  • To identify mutants resistant to ethanol's depressive effects on locomotion.
  • To establish a framework for analyzing drug-induced behavioral changes.

Main Methods:

  • Utilizing genetic screening in C. elegans to isolate ethanol-resistant mutants.
  • Performing behavioral analysis to assess locomotion in identified mutants.
  • Developing a reproducible methodology applicable to various neuroactive compounds.

Main Results:

  • Established a detailed protocol for genetic screening of ethanol-insensitive mutants.
  • Demonstrated the applicability of the methodology for behavioral analysis.
  • Provided a foundation for future research into drug targets.

Conclusions:

  • The described genetic screening method is effective for identifying C. elegans mutants resistant to ethanol.
  • This approach can be adapted to discover genes and pathways mediating responses to diverse neuroactive compounds.
  • The methodology facilitates the identification of molecular targets for drug action.

Related Concept Videos